Literature DB >> 21370010

Nucleic acids extraction from laser microdissected FFPE tissue sections.

Renate Burgemeister1.   

Abstract

Tissue heterogeneity is a common source of unsuccessful experiments. Laser capture microdissection is a tool to prepare homogeneous tissue and cell areas as starting material for reliable and reproducible results as it allows the defined investigation of spatially different tissue areas.Nearly all samples allow the extraction of DNA. Fresh or fresh frozen samples are an ideal source for getting access to high-quality RNA. But also the large archives of formalin-fixed, paraffin-embedded (FFPE) tissue specimens are a valuable source of sample material for RNA extraction. Optimized protocols may help to make the RNA from FFPE material suitable for expression studies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21370010     DOI: 10.1007/978-1-61779-055-3_8

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  12 in total

Review 1.  Quality assurance of RNA expression profiling in clinical laboratories.

Authors:  Weihua Tang; Zhiyuan Hu; Hind Muallem; Margaret L Gulley
Journal:  J Mol Diagn       Date:  2011-10-20       Impact factor: 5.568

Review 2.  Beyond laser microdissection technology: follow the yellow brick road for cancer research.

Authors:  Luc G Legres; Anne Janin; Christophe Masselon; Philippe Bertheau
Journal:  Am J Cancer Res       Date:  2014-01-15       Impact factor: 6.166

3.  Estimation of age-related DNA degradation from formalin-fixed and paraffin-embedded tissue according to the extraction methods.

Authors:  Mototsugu Watanabe; Shinsuke Hashida; Hiromasa Yamamoto; Takehiro Matsubara; Tomoaki Ohtsuka; Ken Suzawa; Yuho Maki; Junichi Soh; Hiroaki Asano; Kazunori Tsukuda; Shinichi Toyooka; Shinichiro Miyoshi
Journal:  Exp Ther Med       Date:  2017-07-17       Impact factor: 2.447

4.  Identification of mRNAs and lincRNAs associated with lung cancer progression using next-generation RNA sequencing from laser micro-dissected archival FFPE tissue specimens.

Authors:  Rom S Leidner; Cheryl L Thompson; Matthew L Morton; Xiaodong Bai; Callie R Merry; Philip A Linden; Ahmad M Khalil
Journal:  Lung Cancer       Date:  2014-03-29       Impact factor: 5.705

Review 5.  World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonisation Project: IV. Tissue collection, processing, and storage in endometriosis research.

Authors:  Amelie Fassbender; Nilufer Rahmioglu; Allison F Vitonis; Paola Viganò; Linda C Giudice; Thomas M D'Hooghe; Lone Hummelshoj; G David Adamson; Christian M Becker; Stacey A Missmer; Krina T Zondervan
Journal:  Fertil Steril       Date:  2014-09-22       Impact factor: 7.329

6.  microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma.

Authors:  Zheng Zhang; Yang Zhang; Xiu-Xuan Sun; Xi Ma; Zhi-Nan Chen
Journal:  Mol Cancer       Date:  2015-01-21       Impact factor: 27.401

7.  Clinical implementation of RNA signatures for pharmacogenomic decision-making.

Authors:  Weihua Tang; Zhiyuan Hu; Hind Muallem; Margaret L Gulley
Journal:  Pharmgenomics Pers Med       Date:  2011-09-08

8.  Semi-nested real-time reverse transcription polymerase chain reaction methods for the successful quantitation of cytokeratin mRNA expression levels for the subtyping of non-small-cell lung carcinoma using paraffin-embedded and microdissected lung biopsy specimens.

Authors:  Yoko Nakanishi; Tetsuo Shimizu; Ichiro Tsujino; Yukari Obana; Toshimi Seki; Fumi Fuchinoue; Sumie Ohni; Toshinori Oinuma; Yoshiaki Kusumi; Tsutomu Yamada; Noriaki Takahashi; Shu Hashimoto; Norimichi Nemoto
Journal:  Acta Histochem Cytochem       Date:  2013-04-12       Impact factor: 1.938

9.  MIR141 Expression Differentiates Hashimoto Thyroiditis from PTC and Benign Thyrocytes in Irish Archival Thyroid Tissues.

Authors:  Emma R Dorris; Paul Smyth; John J O'Leary; Orla Sheils
Journal:  Front Endocrinol (Lausanne)       Date:  2012-09-03       Impact factor: 5.555

10.  Micropapillary: A component more likely to harbour heterogeneous EGFR mutations in lung adenocarcinomas.

Authors:  Yi-Ran Cai; Yu-Jie Dong; Hong-Bo Wu; Zi-Chen Liu; Li-Juan Zhou; Dan Su; Xue-Jing Chen; Li Zhang; Ying-Li Zhao
Journal:  Sci Rep       Date:  2016-04-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.